As of September 2026, 41 US States have medical programs, and 8 US States have special exceptions for only low-THC.
Learn more about each state below.
Each medical state has its own legal specifications for who qualifies for the medical program. Below is a table with all the legal qualifications by state as well as the local state enforcement citations.
| State | Qualifying Conditions | Statutory Citation / Lookup |
|---|---|---|
| Alabama | Autism Spectrum Disorder (ASD); Cancer-related cachexia, nausea or vomiting, weight loss, or chronic pain; Crohn's Disease; Depression; Epilepsy or a condition causing seizures; HIV/AIDS-related nausea or weight loss; Panic disorder; Parkinson's disease; Persistent nausea that is not significantly responsive to traditional treatment, except for nausea related to pregnancy, cannabis-induced cyclical vomiting syndrome, or cannabinoid hyperemesis syndrome; Post Traumatic Stress Disorder (PTSD); Sickle Cell Anemia; Spasticity associated with a motor neuron disease, including Amyotrophic Lateral Sclerosis; Spasticity associated with Multiple Sclerosis or a spinal cord injury; A terminal illness; Tourette's Syndrome; A condition causing chronic or intractable pain in which conventional therapeutic intervention and appropriate therapy is contraindicated or has proved ineffective. | Ala. Code § 20-2A-3(22); SB 46 (2021), Act 2021-450 |
| Alaska | Cancer; HIV/AIDS; cachexia/wasting syndrome; severe pain; severe nausea; seizures; persistent muscle spasms; plus other conditions approved at the state's discretion. | Alaska Stat. §§ 17.37.040, 17.37.060; AS 17.37 |
| Arizona | Cancer; glaucoma; HIV/AIDS; hepatitis C; ALS; Crohn's disease; Alzheimer's disease; PTSD; chronic/severe pain; nausea; seizures; muscle spasms; cachexia/wasting syndrome; any debilitating medical condition or treatment that causes these symptoms. | Ariz. Rev. Stat. § 36-2804.02; Proposition 203 (2010) |
| Arkansas | Cancer; glaucoma; HIV/AIDS; hepatitis C; ALS; Tourette's syndrome; Crohn's disease; PTSD; severe arthritis; fibromyalgia; Alzheimer's disease; plus chronic/debilitating conditions producing cachexia/wasting, peripheral neuropathy, intractable pain, severe nausea, seizures or severe/persistent muscle spasms. | Ark. Const. amend. 98; Arkansas Medical Marijuana Amendment (Issue 6, 2016) |
| California | AIDS; anorexia; arthritis; cancer; chronic pain; glaucoma; migraine; multiple sclerosis; seizures; severe nausea; any other chronic or persistent medical symptom/condition substantially limiting a person's ability to conduct major life activities, or potentially causing serious harm if not alleviated; any other condition for which cannabis provides relief. | Cal. Health & Safety Code § 11362.7 et seq.; Proposition 215 (1996); SB 420 |
| Colorado | Autism spectrum disorder; cancer; HIV/AIDS; glaucoma; cachexia; PTSD; seizures; severe nausea; severe pain; persistent muscle spasms; multiple sclerosis; plus conditions for which a physician determines medical marijuana would be beneficial. | Colo. Rev. Stat. § 25-1.5-106; Colo. Const. art. XVIII, § 14 |
| Connecticut | Cancer; glaucoma; HIV/AIDS; Parkinson's; MS; spinal-cord nervous-tissue damage with intractable spasticity; epilepsy; cachexia; wasting syndrome; Crohn's; PTSD; sickle-cell disease; post-laminectomy syndrome; severe psoriasis/psoriatic arthritis; ALS; ulcerative colitis; CRPS I/II; cerebral palsy; cystic fibrosis; spinal-cord injury; terminal illness; intractable seizure disorder; fibromyalgia-associated spasticity/neuropathic pain; rheumatoid arthritis; postherpetic neuralgia; hydrocephalus with intractable headache; intractable headache syndromes; neuropathic facial pain; muscular dystrophy; osteogenesis imperfecta; degenerative-spinal-disorder neuropathic pain; interstitial cystitis; MALS; vulvodynia/vulvar burning; intractable neuropathic pain; Tourette's; chronic refractory pain; Ehlers-Danlos-associated chronic pain; chronic pancreatitis; Huntington-related movement disorders; autism spectrum disorder; female orgasmic disorder. Separate/stricter list applies to minors. | Conn. Gen. Stat. § 21a-408; § 21a-408(1) |
| Delaware | Cancer; Alzheimer's; ALS; HIV/AIDS; autism; PTSD; anxiety; chronic/debilitating pain; glaucoma; hepatitis C; migraine; nausea; seizures; and other specified conditions. Any diagnosed medical condition/disease where the practitioner determines cannabis would provide palliative or therapeutic benefit. | Del. Code tit. 16, § 4902A et seq.; HB 285 |
| Florida | Cancer; epilepsy; glaucoma; positive status for human immunodeficiency virus; acquired immune deficiency syndrome; posttraumatic stress disorder; amyotrophic lateral sclerosis; Crohn's disease; Parkinson's disease; multiple sclerosis; medical conditions of the same kind or class as or comparable to those enumerated; a terminal condition; chronic nonmalignant pain. | Fla. Stat. § 381.986(2) |
| Georgia | ALS; Alzheimer's; autism spectrum disorder; cancer except non-metastatic skin cancer; epidermolysis bullosa; hospice; stage III HIV; inflammatory bowel disease; intractable pain; lupus; mitochondrial disease; MS; Parkinson's; severe peripheral neuropathy; PTSD; seizure disorders related to epilepsy/traumatic head injury; sickle-cell disease; Tourette's. | Ga. Code Ann. § 16-12-191 et seq.; SB 220 (2026) |
| Hawaii | Severe pain; cachexia/wasting; severe nausea; seizures; severe/persistent muscle spasms; HIV/AIDS; ALS; glaucoma; PTSD; rheumatoid arthritis; lupus; plus other conditions approved by the Department of Health. | Haw. Rev. Stat. § 329-122 |
| Illinois | Alzheimer's; autism; cancer; HIV/AIDS; ALS; Crohn's; ulcerative colitis; glaucoma; hepatitis C; HIV; multiple sclerosis; Parkinson's; PTSD; seizures; spinal-cord disease/injury; migraines; chronic pain; irritable bowel syndrome; Tourette's; fibrous dysplasia; muscular dystrophy; Sjögren's; Arnold-Chiari; hydrocephalus; chronic inflammatory demyelinating polyneuropathy; plus numerous additional statutory conditions. Patients who are prescribed or could be prescribed opioids may also qualify. | 410 ILCS 130/10; Compassionate Use of Medical Cannabis Program Act |
| Kentucky | Cancer; chronic/severe/intractable/debilitating pain; epilepsy/seizure disorders; MS; muscle spasms; chronic nausea or cyclical vomiting; PTSD; and other conditions approved by the Kentucky Center for Cannabis. | Ky. Rev. Stat. Ch. 218B; SB 47 (2023) |
| Louisiana | Autism spectrum disorder; cancer; HIV/AIDS; cachexia/wasting; Crohn's disease; epilepsy; glaucoma; Parkinson's; PTSD; seizures; severe muscle spasms; spasticity; traumatic brain injury; intractable pain; and other conditions/uses authorized under the state's physician-certification framework. | La. Rev. Stat. § 40:1046 |
| Maine | A medical condition that is debilitating or causes symptoms that can be alleviated through medical cannabis, with physician certification. | 22 M.R.S. § 2422; § 2424-A |
| Maryland | A chronic or debilitating disease or medical condition, or its treatment, that produces cachexia/wasting, severe or chronic pain, severe nausea, seizures, or severe/persistent muscle spasms, or another condition for which cannabis provides therapeutic/palliative benefit. | Md. Code, Alcoholic Beverages & Cannabis § 36-301 et seq. |
| Massachusetts | A debilitating medical condition, including cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, PTSD and other conditions that produce comparable symptoms or for which the physician believes cannabis provides therapeutic/palliative benefit. | Mass. Gen. Laws ch. 94G, § 2; ch. 94I |
| Michigan | Cancer; glaucoma; HIV/AIDS; hepatitis C; ALS; Crohn's; agitation of Alzheimer's; nail-patella; PTSD; OCD; arthritis; spinal-cord injury; inflammatory bowel disease; autism; chronic pain; cerebral palsy; chronic colitis; and other debilitating medical conditions or treatments causing wasting, severe/chronic pain, severe nausea, seizures or severe/persistent muscle spasms. | Mich. Comp. Laws § 333.26423; Michigan Medical Marihuana Act |
| Minnesota | Cancer; glaucoma; HIV/AIDS; Tourette's; ALS; seizures; severe/persistent muscle spasms; Crohn's disease; terminal illness; intractable pain; PTSD; autism spectrum disorder; obstructive sleep apnea; Alzheimer's disease; chronic pain; sickle-cell disease; and other conditions designated by the Commissioner of Health. | Minn. Stat. § 342.51; § 342.50 |
| Mississippi | Cancer; Parkinson's; Huntington's; muscular dystrophy; glaucoma; spastic quadriplegia; HIV/AIDS; hepatitis; ALS; Crohn's; ulcerative colitis; sickle-cell anemia; Alzheimer's; agitation of dementia; PTSD; autism; spinal-cord disease; severe injury; chronic pain meeting statutory requirements; and other qualifying conditions established by law. | Miss. Code Ann. § 41-137-1 et seq. |
| Missouri | Cancer; epilepsy; glaucoma; migraine; debilitating psychiatric disorders including PTSD; HIV/AIDS; a chronic medical condition normally treated with a prescription medication that could lead to physical/psychological dependence; any terminal illness; and any other chronic, debilitating or other medical condition that a physician believes would benefit from medical marijuana. | Mo. Const. art. XIV, § 1; Mo. Rev. Stat. § 195.800 et seq. |
| Montana | Cancer; glaucoma; HIV/AIDS; AIDS wasting syndrome; ALS; Crohn's disease; agitation of Alzheimer's; PTSD; autism; intractable nausea; cachexia/wasting; chronic pain; severe or persistent muscle spasms; seizures; and other debilitating medical conditions. | Mont. Code Ann. § 50-46-301 et seq. |
| Nebraska | A medically diagnosed condition for which a healthcare practitioner recommends medical cannabis. | Neb. Rev. Stat. § 71-24,101 et seq.; Neb. Const. art. I, § 25 |
| Nevada | Cancer; HIV/AIDS; glaucoma; PTSD; severe pain; cachexia; severe nausea; seizures; persistent muscle spasms; autism; anxiety disorder; autoimmune disease; anorexia nervosa; opioid dependence; neuropathic condition; plus other conditions approved by the Department of Health and Human Services. | Nev. Rev. Stat. § 678C.140 |
| New Hampshire | Cancer; glaucoma; HIV/AIDS; hepatitis C; ALS; Crohn's; multiple sclerosis; spinal-cord injury; muscular dystrophy; Parkinson's; Alzheimer's; PTSD; chronic pain; autism; Ehlers-Danlos; moderate-to-severe pain; severe nausea; seizures; cachexia/wasting; severe muscle spasms; and other qualifying debilitating/terminal conditions. | N.H. Rev. Stat. § 126-X:1 et seq. |
| New Jersey | Amyotrophic lateral sclerosis; anxiety; chronic pain related to musculoskeletal disorders; chronic pain of visceral origin; migraine headaches; multiple sclerosis; opioid-use disorder as adjunctive treatment; PTSD; Tourette's; seizure disorders including epilepsy; glaucoma; HIV/AIDS; cancer; inflammatory bowel disease; terminal illness; and other conditions added by the state. | N.J. Stat. Ann. § 24:6I-1 et seq. |
| New Mexico | ALS; autism spectrum disorder; cancer; chronic pain; Crohn's disease; glaucoma; hepatitis C; HIV/AIDS; Huntington's disease; intractable nausea; multiple sclerosis; PTSD; Parkinson's; spinal-cord damage; substance-use disorder; Alzheimer's; severe anorexia/cachexia; and numerous other conditions approved through the program. | N.M. Stat. § 26-2B-1 et seq. |
| New York | Cancer; HIV/AIDS; ALS; Parkinson's; MS; spinal-cord injury; epilepsy; IBD; neuropathy; chronic pain; PTSD; opioid-use disorder; substance-use disorder; autism; Alzheimer's; and any condition for which a practitioner believes medical cannabis would provide therapeutic or palliative benefit. | N.Y. Pub. Health Law § 3360 et seq. |
| North Dakota | Cancer; HIV/AIDS; ALS; PTSD; Alzheimer's/dementia-related agitation; Crohn's; fibromyalgia; spinal stenosis; chronic/debilitating pain; glaucoma; epilepsy/seizures; nausea; cachexia/wasting; severe/persistent muscle spasms; and other debilitating medical conditions. | N.D. Cent. Code § 19-24.1-01 et seq. |
| Ohio | AIDS; ALS; Alzheimer's; cancer; chronic traumatic encephalopathy; Crohn's; epilepsy; fibromyalgia; glaucoma; HIV; inflammatory bowel disease; multiple sclerosis; chronic/severe pain; Parkinson's; PTSD; spinal-cord disease/injury; sickle-cell anemia; Tourette's; traumatic brain injury; ulcerative colitis; and other conditions approved by the state. | Ohio Rev. Code § 3796.01 et seq. |
| Oklahoma | No fixed statutory list of qualifying conditions. A physician may recommend medical marijuana to a patient when the physician determines that the patient has a medical condition for which medical marijuana may provide benefit. | 63 Okla. Stat. § 420 et seq.; SQ 788 (2018) |
| Oregon | Cancer; HIV/AIDS; glaucoma; degenerative/pervasive neurological condition; cachexia; severe pain; severe nausea; seizures; PTSD; persistent muscle spasms; and other conditions added by the Oregon Health Authority. | Or. Rev. Stat. § 475C.770 et seq. |
| Pennsylvania | ALS; anxiety disorders; autism; cancer; Crohn's; damage to nervous tissue of spinal cord; dyskinetic/spastic movement disorders; epilepsy; glaucoma; HIV/AIDS; Huntington's; IBD; intractable neuropathic pain; MS; neurodegenerative diseases; opioid-use disorder; Parkinson's; PTSD; sickle-cell anemia; severe chronic/intractable pain; seizures; Tourette's. | 35 Pa. Stat. § 10231.101 et seq. |
| Rhode Island | Cancer; glaucoma; HIV/AIDS; hepatitis C; Alzheimer's; PTSD; severe debilitating pain; cachexia; severe nausea; seizures; persistent muscle spasms; autism; and other conditions approved by the Department of Health. | R.I. Gen. Laws § 21-28.6-1 et seq. |
| South Dakota | HIV/AIDS; MS; ALS; cancer/cancer treatment; Crohn's; epilepsy; PTSD; and medical conditions producing wasting syndrome, severe debilitating pain, severe nausea, seizures, or severe/persistent muscle spasms. | S.D. Codified Laws § 34-20G-1 et seq.; Constitutional Amendment A / IM 26 |
| Texas | Epilepsy/seizure disorder; MS; spasticity; ALS; autism; terminal illness; PTSD; traumatic brain injury; neurodegenerative diseases; and chronic pain meeting the statutory definition. | Tex. Health & Safety Code § 487.001 et seq.; HB 3703 (2015); HB 46 (2025) |
| Utah | HIV or acquired immune deficiency syndrome; Alzheimer's disease; amyotrophic lateral sclerosis; cancer; cachexia; persistent nausea that is not significantly responsive to traditional treatment, except for nausea related to pregnancy, cannabis-induced cyclical vomiting syndrome, or cannabinoid hyperemesis syndrome; Crohn's disease; ulcerative colitis; epilepsy; debilitating seizures; multiple sclerosis; debilitating muscle spasms; PTSD; autism; terminal illness; hospice care; acute pain; chronic pain; and other conditions approved through the Compassionate Use Board. | Utah Code § 26B-4-203 |
| Vermont | Cancer; multiple sclerosis; HIV/AIDS; PTSD; Crohn's; Parkinson's; glaucoma; chronic pain; cachexia; severe nausea; or seizures. | Vt. Stat. tit. 18, § 4472 |
| Virginia | There is no list of qualifying conditions. A written certification may be issued by a physician, physician's assistant, or nurse practitioner when the practitioner determines that cannabis may benefit the patient. | Va. Code § 4.1-1601 et seq.; § 4.1-1602 |
| Washington | Cancer; HIV/AIDS; multiple sclerosis; seizure disorders; spastic disorders; intractable pain; glaucoma; Crohn's disease; hepatitis C; PTSD; and diseases causing nausea, vomiting or appetite loss; plus diseases or conditions approved by the state. | Wash. Rev. Code § 69.51A.010 et seq. |
| West Virginia | Terminal illness; cancer; HIV/AIDS; ALS; Parkinson's; MS; spinal-cord damage; epilepsy; neuropathies; Huntington's disease; Crohn's; PTSD; intractable seizures; sickle-cell anemia; and certain forms of intractable pain. | W. Va. Code § 16A-3-2 et seq. |
| --- STATES WITH LIMITED ACCESS (THC% Limitations) --- The specific amount of THC allowable and penalties vary by state | ||
| Indiana | Indiana's low-THC/CBD law does not function as a conventional medical-cannabis patient registry with a defined qualifying-condition list. The law primarily addresses lawful possession of qualifying CBD products. | Ind. Code § 35-48-4-10.5 |
| Iowa | Chronic pain; terminal illness; MS; seizures; HIV/AIDS; Crohn's disease; ALS; Parkinson's disease; cancer under specified circumstances; PTSD; autism with self-injurious/aggressive behavior; and other conditions approved under the state's medical-cannabis framework. | Iowa Code § 124E.2 et seq. |
| Kansas | CBD/low-THC protection is primarily an affirmative defense rather than a comprehensive medical program. The law allows possession of qualifying CBD products with THC limits; it does not create a conventional dispensary-based qualifying-patient program. | Kan. Stat. Ann. § 21-5705; Kansas Legislature medical cannabis legislation |
| North Carolina | Epilepsy/seizure disorders. | N.C. Gen. Stat. § 90-94.1; Epilepsy Alternative Treatment Act |
| South Carolina | Severe epilepsy that is not adequately treated by traditional medical therapies. | S.C. Code Ann. § 44-53-1810 et seq.; Julian's Law |
| Tennessee | Alzheimer's disease; ALS; end-stage cancer; inflammatory bowel disease including Crohn's and ulcerative colitis; epilepsy/seizures; MS; Parkinson's disease; HIV/AIDS; sickle-cell disease. | Tenn. Code Ann. § 39-17-402 et seq.; § 39-17-1362 |
| Wisconsin | No conventional list of qualifying medical conditions. The law provides an exception allowing possession of cannabidiol in a form without a psychoactive effect when supported by physician certification. | Wis. Stat. § 961.32(2m) |
| Wyoming | Intractable epilepsy or seizure disorders. | Wyo. Stat. § 35-7-1060 |
Note: This table is intended as a public educational reference and is not legal advice. Cannabis laws and regulations change frequently. Users should verify the cited statute and current state regulations before relying on this information. Last reviewed: September 2026.